BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Markowski MC, Eisenberger MA, Zahurak M, Epstein JI, Paller CJ. Sarcomatoid Carcinoma of the Prostate: Retrospective Review of a Case Series From the Johns Hopkins Hospital. Urology. 2015;86:539-543. [PMID: 26126695 DOI: 10.1016/j.urology.2015.06.011] [Cited by in Crossref: 23] [Cited by in F6Publishing: 13] [Article Influence: 3.3] [Reference Citation Analysis]
Number Citing Articles
1 Yong C, Moose DL, Bannick N, Gutierrez WR, Vanneste M, Svensson R, Breheny P, Brown JA, Dodd RD, Cohen MB, Henry MD. Locally invasive, castrate-resistant prostate cancer in a Pten/Trp53 double knockout mouse model of prostate cancer monitored with non-invasive bioluminescent imaging. PLoS One 2020;15:e0232807. [PMID: 32986721 DOI: 10.1371/journal.pone.0232807] [Reference Citation Analysis]
2 Jayasinghe KI, Abeysinghe AHMGB. Sarcomatoid carcinoma of the prostate presenting as bilateral cervical lymphadenopathy: a rare case report. Afr J Urol 2022;28. [DOI: 10.1186/s12301-022-00274-x] [Reference Citation Analysis]
3 Li X, He Y, Zhu J, Pang H, Lin Y, Zheng J. Apatinib-based targeted therapy against pulmonary sarcomatoid carcinoma: a case report and literature review. Oncotarget 2018;9:33734-8. [PMID: 30263099 DOI: 10.18632/oncotarget.25989] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
4 Aggarwal S, Mitra S, Dewan A, Durga G. Carcinosarcoma prostate with osteosarcomatous differentiation: a rare de novo presentation. BMJ Case Rep 2019;12:e230116. [PMID: 31196973 DOI: 10.1136/bcr-2019-230116] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
5 Humphrey PA. Histopathology of Prostate Cancer. Cold Spring Harb Perspect Med 2017;7:a030411. [PMID: 28389514 DOI: 10.1101/cshperspect.a030411] [Cited by in Crossref: 29] [Cited by in F6Publishing: 24] [Article Influence: 5.8] [Reference Citation Analysis]
6 Inamura K. Prostatic cancers: understanding their molecular pathology and the 2016 WHO classification. Oncotarget 2018;9:14723-37. [PMID: 29581876 DOI: 10.18632/oncotarget.24515] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
7 Chen W, Han DJ, Fu GQ, Lin W, Liang Y. Long term follow-up of surgery management of prostate leiomyosarcoma metastasized to the rib: A case report and literature review. Mol Clin Oncol 2016;5:132-4. [PMID: 27330784 DOI: 10.3892/mco.2016.898] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
8 Yen CH, Lai CC, Liao CC, Wang SF, Liao YJ, Tung CY, Hung JH, Huang SF, Chen YA. Characterization of a new murine cell line of sarcomatoid hepatocellular carcinoma and its application for biomarker/therapy development. Sci Rep. 2017;7:3052. [PMID: 28596515 DOI: 10.1038/s41598-017-03164-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
9 Al-Saadi N, Al-Musawi S, Khan Y, Dawam D. An unusual presentation of prostate cancer posing a diagnostic dilemma: A case report. Urol Case Rep 2021;34:101432. [PMID: 33088717 DOI: 10.1016/j.eucr.2020.101432] [Reference Citation Analysis]
10 Urrea YR, Epstein JI. Sarcomatoid carcinoma associated with small cell carcinoma of the urinary bladder: a series of 28 cases. Human Pathology 2017;67:169-75. [DOI: 10.1016/j.humpath.2017.08.008] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
11 Kan A, Guo RP. The prognosis of subsequent surgical treatment in patients with sarcomatoid carcinoma in the liver: A retrospective study. Int J Surg 2018;55:145-51. [PMID: 29860126 DOI: 10.1016/j.ijsu.2018.05.736] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
12 Wei W, Li QG, Long X, Hu GH, He HJ, Huang YB, Yi XL. Sarcomatoid carcinoma of the prostate with bladder invasion shortly after androgen deprivation: Two case reports. World J Clin Cases 2021; 9(7): 1668-1675 [PMID: 33728311 DOI: 10.12998/wjcc.v9.i7.1668] [Reference Citation Analysis]
13 Acosta AM, Senseng C, Kim G, Sekosan M, Ree N. Sarcomatoid carcinoma of the prostate with adenocarcinoma, squamous cell carcinoma, and heterologous components. APMIS 2016;124:719-22. [PMID: 27197712 DOI: 10.1111/apm.12548] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
14 Lordello L, Webb P, Oliva E. Vulvar Carcinosarcoma Composed of Intestinal-type Mucinous Adenocarcinoma Associated With Anaplastic Pleomorphic and Spindle Cell Carcinoma and Heterologous Chondrosarcomatous and Osteosarcomatous Elements: A Case Report and Review of the Literature. International Journal of Gynecological Pathology 2018;37:93-100. [DOI: 10.1097/pgp.0000000000000385] [Cited by in Crossref: 5] [Article Influence: 1.3] [Reference Citation Analysis]
15 Zhao S, Komori T, Inoue A, Aoki M, Matsushita S. Rare case of sarcomatoid carcinoma of the prostate with metastatic skin tumor manifestation. J Dermatol 2020;47:e304-5. [PMID: 32515114 DOI: 10.1111/1346-8138.15426] [Reference Citation Analysis]
16 Selvaraj N, Ragavan N, Shah SN. Carcinosarcoma of the Prostate Masquerading as Benign Prostatic Enlargement: Lesson Learned. Eur Urol Open Sci 2021;23:9-12. [PMID: 34337484 DOI: 10.1016/j.euros.2020.11.006] [Reference Citation Analysis]